Literature DB >> 16332398

Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil.

Rosangela Rodrigues1, Luciene C Scherer, Cristina M Oliveira, Heitor Moreira Franco, Rosa Dea Sperhacke, Joao Leandro Paula Ferreira, Simone Martins Castro, Isete Maria Stella, Luis Fernando Macedo Brigido.   

Abstract

We describe preliminary molecular characterization of HIV-1 pol from 108 consecutive HIV seropositive users of a Voluntary Counseling and Testing (VCT) site of Porto Alegre city, the major metropolitan area in the south of Brazil. Protease and partial reverse transcriptase regions were retrotranscribed from plasma HIV-1 RNA and sequenced after direct nested PCR. Principal antiretroviral resistance mutations (ARM) were observed in 3% of the samples, two cases with K103N and one with M41L, L210W and T215Y, all in HIV-1 clade B infected men. At protease region, no principal mutations were observed, but polymorphisms at secondary codons were frequent. Contrary to other areas in the country where clade B dominates, HIV-1 clade C genomes predominated in this study (58%), clade B (32%) and clade F1 (3%). Of the genomes clustering in clade C, almost half (43%) had a small clade B segment at reverse transcriptase, forming a sub-cluster within clade C with a similar recombinant structure and carrying new amino acid signatures. Other mosaic genomes were also observed (7%). The low prevalence of resistance mutations is consistent with previous observations at this geographical location but the high frequency of HIV-1 clade C and CB mosaics seems pre-eminent and warns close monitoring.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16332398     DOI: 10.1016/j.virusres.2005.10.004

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  14 in total

Review 1.  Antiretroviral therapy : optimal sequencing of therapy to avoid resistance.

Authors:  Jorge L Martinez-Cajas; Mark A Wainberg
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  Molecular epidemiology of HIV type 1 in newly diagnosed patients in southern Spain.

Authors:  Michael J McConnell; Fernando Docobo-Pérez; Rosario C Mata; Felipe Fernandez-Cuenca; Pompeyo Viciana; Luis F López-Cortés; Mónica Trastoy; Jerónimo Pachón; Pilar Pérez-Romero
Journal:  AIDS Res Hum Retroviruses       Date:  2008-06       Impact factor: 2.205

3.  Global analysis of sequence diversity within HIV-1 subtypes across geographic regions.

Authors:  Austin Huang; Joseph W Hogan; Sorin Istrail; Allison Delong; David A Katzenstein; Rami Kantor
Journal:  Future Virol       Date:  2012-05       Impact factor: 1.831

Review 4.  Transmitted drug resistance among antiretroviral-naive patients with established HIV type 1 infection in Santo Domingo, Dominican Republic and review of the Latin American and Caribbean literature.

Authors:  Julie E Myers; Barbara S Taylor; Rita A Rojas Fermín; Emily Virginia Reyes; Catherine Vaughan; Lina José; Carmen Javier; Ramona Franco Estévez; Yeycy Donastorg Cabral; Arelis Batista; Yolanda Lie; Eoin Coakley; Scott M Hammer; Karen Brudney
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-23       Impact factor: 2.205

5.  Transmitted drug resistance in nonsubtype B HIV-1 infection.

Authors:  Philip A Chan; Rami Kantor
Journal:  HIV Ther       Date:  2009-09-01

6.  An optimized nested polymerase chain reaction (PCR) approach allows detection and characterization of human immunodeficiency virus type 1 (HIV-1) env and gag genes from clinical samples.

Authors:  Dayse Locateli; Patricia H Stoco; Carlos R Zanetti; Aguinaldo R Pinto; Edmundo C Grisard
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

7.  Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in São Paulo, Brazil.

Authors:  Sabri Saeed Sanabani; Evelyn Regina de Souza Pastena; Walter Kleine Neto; Vanessa Pouza Martinez; Ester Cerdeira Sabino
Journal:  Virol J       Date:  2010-04-16       Impact factor: 4.099

8.  Temporal dynamics of HIV-1 circulating subtypes in distinct exposure categories in southern Brazil.

Authors:  Sabrina Em Almeida; Rubia M de Medeiros; Dennis M Junqueira; Tiago Gräf; Caroline P B Passaes; Gonzalo Bello; Mariza G Morgado; Monick L Guimarães
Journal:  Virol J       Date:  2012-12-12       Impact factor: 4.099

9.  Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV.

Authors:  Lilian A Inocencio; Anderson A Pereira; Maria Cecilia A Sucupira; José Carlos C Fernandez; Célia P Jorge; Denise Fc Souza; Helena T Fink; Ricardo S Diaz; Irina M Becker; Theodoro A Suffert; Monica B Arruda; Olinda Macedo; Mariangela Bg Simão; Amilcar Tanuri
Journal:  J Int AIDS Soc       Date:  2009-09-18       Impact factor: 5.396

10.  Transmitted Drug Resistance among People Living with HIV/Aids at Major Cities of Sao Paulo State, Brazil.

Authors:  Joao Leandro Paula Ferreira; Rosangela Rodrigues; Andre Minhoto Lança; Valeria Correia de Almeida; Simone Queiroz Rocha; Taisa Grotta Ragazzo; Denise Lotufo Estevam; Luis Fernando de Macedo Brigido
Journal:  Adv Virol       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.